Search

everythinglearnresearchcommunity

for

Search:↓

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Tracnil™, a mix of myo-inositol, folic acid, and vitamin D3, safely reduced acne, improved excessive hair growth, and fixed irregular periods in overweight women with PCOS.

People with polycystic ovary syndrome are more likely to have poor sleep, restless legs syndrome, anxiety, and depression.

Female pattern hair loss severity is linked to physical signs of high androgens, not blood hormone levels.

High BMI worsens hair growth in women with PCOS.

Oxidative stress is higher in women with PCOS, especially if they're obese, and it may increase their risk of heart disease.

Women with PCOS may have higher bad cholesterol and are at risk for blood sugar issues; lifestyle changes are recommended.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Genetic risk for PCOS can affect children's growth, metabolism, and development from early life into adulthood.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

PCOS may be influenced by factors in the blood, not just the ovaries.

High levels of fatty acids are linked to increased androgen production and inflammation in women with PCOS, which may affect IVF outcomes.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Hair loss in young men linked to higher risk of insulin resistance and metabolic issues.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

Taking metformin with intense-pulsed-light therapy improves hair removal for people with PCOS.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Blood removal and birth control pills both helped with hormone levels in women with PCOS, but birth control was better for regular periods and blood removal had fewer side effects.

A postmenopausal woman's high testosterone levels and symptoms improved after removing a tumor from her ovary.

Chromium picolinate was better tolerated than metformin for PCOS with fewer side effects.

Taking metformin with intense pulsed light therapy improves hair removal for women with PCOS.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.